FDA

FDA actions on menopause treatments

Every approval, label change and safety notice FDA has issued for the menopause treatments we follow, newest first: 18 since Dec 16, 2024 (11 label changes, 7 approvals). Read from FDA's press announcements and its record of approved drugs every day, most recently Nov 19, 2026.

The boxed warning on hormone therapy changes one label at a time; where each stands today is on the boxed warning page. What each treatment costs online is on its own page.

2026

2025

2024

  • Dec 16, 2024

    Label change: FDA approved a labeling supplement for Veozah

    A labeling supplement changes the wording of the prescribing information, such as its warnings, dosing or safety data. The current label is the record of what changed.

    FDA Drugs@FDA, its record (accessdata.fda.gov) · Fezolinetant: Veozah (fezolinetant) prices

FDA actions as FDA's own records state them. A label change can be any change to a product's prescribing information; an approval of a generic does not mean a pharmacy stocks it yet. Not medical advice.